Ready to jumpstart your #career? Our early talent programs are where potential meets opportunity. Join us and be part of a team that values your fresh perspective: https://bit.ly/3Dkd67x #AbbVieLife [Video description: An AbbVie employee shares details about our early talent programs in various office locations.]
AbbVie
Fabricación de productos farmacéuticos
North Chicago, Illinois 1.477.004 seguidores
Sobre nosotros
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. AbbVie employs approximately 26,000+ people worldwide and markets medicines in more than 170+ countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter and like us on Facebook.
- Sitio web
-
http://www.abbvie.com
Enlace externo para AbbVie
- Sector
- Fabricación de productos farmacéuticos
- Tamaño de la empresa
- Más de 10.001 empleados
- Sede
- North Chicago, Illinois
- Tipo
- Empresa pública
- Especialidades
- Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics y Eye Care
Ubicaciones
Empleados en AbbVie
Actualizaciones
-
May your holiday season be merry and bright. #HappyHolidays from all of us, to you and yours. [Video description: Ornaments animate on-screen featuring scientific icons and text reading, “Happy Holidays.”]
-
Creating the medicines of the future requires making big bets in #science and #technology today. Learn how the AbbVie Research Collaborative is helping our #scientists incorporate patient voices into the research process: https://bit.ly/4gkxUKF [Video description: Animated visuals highlighting aspects of patient health profiles and differing metrics, followed by footage of real people and scientists. On-screen text reads, “Click the link to see how we’re making the case for big bets. People. Passion. Possibilities.”]
-
Patients are at the center of our #ParkinsonsDisease research. We’ve made it our mission to help preserve personhood and support people around the world. Still, there is more to be done to fill in gaps in care. Learn more: https://bit.ly/3Di42QK [Video description: Hella Tulp, nurse practitioner, shares her point of view on the importance of enhancing care for Parkinson’s disease.]
-
JUST IN: We’ve signed a definitive agreement to acquire Nimble Therapeutics to further strengthen our #immunology pipeline. This agreement represents an important growth opportunity and supports our ongoing commitment to developing novel medicines for people living with #autoimmune diseases. Learn more: https://bit.ly/3Bv58Ij [Video description: On-screen text reads, “Immunology News .”]
-
What does a #cure look like? The answer may vary from one therapeutic area to the next. But our #researchers are determined to ultimately find cures for patients. Read more: https://bit.ly/4fbNcjI [Video description: On-screen text reads, “The pathway to a cure” followed by 5 steps along the pathway: precedented symptom relief; unprecedented symptom relief; transformative therapies; on treatment, disease-free state; cure.]
-
Aliada Therapeutics is now part of AbbVie. This #acquisition expands our neuroscience pipeline with an investigational therapy in #Alzheimers disease and a novel blood-brain barrier-crossing technology. Learn more: https://bit.ly/3ON5OMh $ABBV [Video description: On-screen text reads, “Aliada Therapeutics is now part of AbbVie” followed by the AbbVie and Aliada Therapeutics logos.]
-
One of our goals in #neuroscience research, in partnership with the patient community, continues to be developing new solutions for people living with #ParkinsonsDisease to preserve one’s personhood. Read more from Parkinson's Europe about enhancing care: https://bit.ly/3Zzs5lM [Video description: Amelia Hursey, Research Manager at Parkinson’s Europe, explains how patient advocacy groups help patients in need.]
-
NEWS: Today, we announced results from a Phase 3 trial of our investigational #ParkinsonsDisease treatment. Read more about the trial: https://bit.ly/3D8169h [Video description: On-screen text reads, “Neuroscience News.”]
-
#Science requires discipline – pioneering research requires risk-taking. See how our researchers bet on themselves to drive innovation in #oncology. https://bit.ly/3OFixk2 [Video description: Andrew Petros, Research Fellow, AbbVie, says, “We had a problem. The right tool to solve the problem didn’t exist, so we invented the tool, which has become the industry standard. And in the end, the best part is that we solved the right problem, allowing us to develop a medicine that is making a lasting impact for patients.”]
Páginas asociadas
Páginas similares
Buscar empleos
Acciones
ABBV
NYSE
20 minutos de retraso
175,62 US$
4,1 (2,39 %)
- Apertura
- 171,794
- Mínimo
- 170,66
- Máximo
- 176,8
Datos de Refinitiv
Consulta más información enFinanciación
AbbVie
2 rondas en total
Ver más información en Crunchbase
Última ronda
Deuda tras OPV
Enlace externo a Crunchbase para la última ronda de financiación
15.000.000.000,00 US$